日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ENHANCE: a community partnership charting the evolution of early-life cystic fibrosis disease manifestations in a new era of management

ENHANCE:一项社区合作项目,旨在记录囊性纤维化早期疾病在新管理时代的表现演变。

Urquhart, Don S; Linnane, Barry; Saunders, Clare J; Abkir, Mary; Georgiopoulos, Anna M; Dobra, Rebecca; Carroll, Sarah; Still, Maddie; Cox, Desmond W; Fitzpatrick, Emer; Beegan, Aidan; Thursfield, Rebecca; Balfe, Jen; Tarr, Alison; Lester, Karen; Cunningham, Aoife; Perrem, Lucy; Davies, Jane C; McNally, Paul

Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D-Related Chronic Liver Disease Deaths in Australia

针对丁型肝炎感染的反射性检测:降低澳大利亚丁型肝炎相关慢性肝病死亡率的独特契机

Howell, Jessica; Andersson, Lauren; Levy, Miriam T; O'Beirne, James; Adams, Leon; Irvine, Katharine; Majumdar, Avik; Ahlenstiel, Golo; Jackson, Kathy; Hajkowicz, Krispin; Doyle, Joseph; Davies, Jane; Cherian, Sarah; Dimech, Wayne; Thompson, Alexander J

Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials

最大限度提高治疗成功率:按顺序参与囊性纤维化核酸疗法试验

Mayer-Hamblett, Nicole; Kerper, Natanya R; Clancy, John P; Davies, Jane C; Taylor-Cousar, Jennifer L; Donaldson, Scott H; Bell, Scott C; Jain, Raksha; Simmonds, Nicholas J; Mall, Marcus A; Goss, Christopher H; Rayment, Jonathan H; Setiawan, Linda; Pilewski, Joseph M

Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy

rSIV.F/HN(一种用于囊性纤维化基因治疗的混合慢病毒载体)的药理学和临床前安全性概况

Moiseenko, Alena; Sinadinos, Anthony; Sergijenko, Ana; Pineault, Kyriel; Saleh, Aarash; Nekola, Konradin; Strang, Nathalie; Eleftheraki, Anastasia; Boyd, A Christopher; Davies, Jane C; Gill, Deborah R; Hyde, Stephen C; McLachlan, Gerry; Rath, Tim; Rothe, Michael; Schambach, Axel; Hobbie, Silke; Schuler, Michael; Maier, Udo; Thomas, Matthew J; Mennerich, Detlev; Schmidt, Manfred; Griesenbach, Uta; Alton, Eric W F W; Kreuz, Sebastian

Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study

在患有囊性纤维化且携带 F508del 杂合子和最小功能突变的 ≥6 岁儿童中,使用 Elexacaftor/tezacaftor/ivacaftor 进行治疗:一项为期 96 周的开放标签扩展研究的结果

Mall, Marcus A; Wainwright, Claire E; Legg, Julian; Chilvers, Mark; Gartner, Sylvia; Dittrich, Anna-Maria; Stehling, Florian; Conner, Sarah; Grant, Sebastian; Suresh, Nina; Weinstock, Tanya G; Davies, Jane C

Managing an ageing cystic fibrosis population: challenges and priorities

管理老龄化囊性纤维化患者群体:挑战与优先事项

Frost, Freddy J; Peckham, Daniel G; Felton, Imogen C; Snowball, Joanna E; Gray, Robert D; Jones, Andrew M; Simmonds, Nicholas J; Lord, Robert W; Lip, Gregory Y H; Chandler, Hannah; Murphy, Kevin; Downey, Damian G; Sheppard, David N; Davies, Jane C; Bull, Jane; Sommer, Paula; Cupid, Belinda; Allen, Lucy; Duckers, Jamie

HLA-B*15:01-positive severe COVID-19 patients lack CD8(+) T cell pools with highly expanded public clonotypes

HLA-B*15:01阳性的重症COVID-19患者缺乏具有高度扩增的公共克隆型的CD8(+) T细胞库

Rowntree, Louise C; Allen, Lilith F; Hagen, Ruth R; McQuilten, Hayley A; Quadeer, Ahmed A; Chaurasia, Priyanka; Kaewpreedee, Prathanporn; Lee, Kelly W K; Cohen, Carolyn A; Petersen, Jan; Littler, Dene R; Habel, Jennifer R; Zhang, Wuji; Cheng, Samuel M S; Chan, Ken Ka Pang; Kwok, Janette S Y; Leung, Kathy S M; Wu, Joseph T; Lee, Cheuk-Kwong; Davies, Jane; Pannaraj, Pia S; Kaity Allen, E; Thomas, Paul G; Tosif, Shidan; Crawford, Nigel W; Lappas, Martha; Thevarajan, Irani; Lewin, Sharon R; Kent, Stephen J; Juno, Jennifer A; Bond, Katherine A; Williamson, Deborah A; Holmes, Natasha E; Smibert, Olivia C; Gordon, Claire L; Trubiano, Jason A; Kotsimbos, Tom C; Cheng, Allen C; Efstathiou, Claudia; Turtle, Lance; Thwaites, Ryan S; Brightling, Christopher E; Rossjohn, Jamie; McKay, Matthew R; Tian, Jinmin; Liu, William Jun; Gao, George Fu; Xu, Jianqing; Sonehara, Kyuto; Ishii, Ken J; Namkoong, Ho; Okada, Yukinori; Peiris, Malik; Hui, David S C; Poon, Leo L M; Doherty, Peter C; Nguyen, Thi H O; Valkenburg, Sophie A; Kedzierska, Katherine

tesG expression as a potential clinical biomarker for chronic Pseudomonas aeruginosa pulmonary biofilm infections

tesG表达作为慢性铜绿假单胞菌肺生物膜感染的潜在临床生物标志物

Wannigama, Dhammika Leshan; Hurst, Cameron; Monk, Peter N; Hartel, Gunter; Ditcham, William Graham Fox; Hongsing, Parichart; Phattharapornjaroen, Phatthranit; Ounjai, Puey; Torvorapanit, Pattama; Jutivorakool, Kamonwan; Luk-In, Sirirat; Nilgate, Sumanee; Rirerm, Ubolrat; Tanasatitchai, Chanikan; Miyanaga, Kazuhiko; Cui, Longzhu; Ragupathi, Naveen Kumar Devanga; Rad, S M Ali Hosseini; Khatib, Aisha; Storer, Robin James; Ishikawa, Hitoshi; Amarasiri, Mohan; Charuluxananan, Somrat; Leelahavanichkul, Asada; Kanjanabuch, Talerngsak; Higgins, Paul G; Davies, Jane C; Stick, Stephen M; Kicic, Anthony; Chatsuwan, Tanittha; Shibuya, Kenji; Abe, Shuichi

Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation

临床试验入组肺功能测定阈值:亟需重新评估

Bokobza, Idan; Le Sayec, Melanie; Bossley, Cara; Brugha, Rossa; Davies, Jane Carolyn; Dawson, Charlotte; Holt, Lucy; Hughes, Dominic A; Needham, Yasmine; Pao, Caroline; Ruiz, Gary; Safavi, Shahideh; Saunders, Clare; Shafi, Nadia; Simmonds, Nicholas J; Waller, Michael D; Watson, Danie; Davies, Gwyneth

Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, Australia

澳大利亚北领地C4亚基因型乙型肝炎感染的疾病进展和治疗需求:一项回顾性队列研究

Martin, Genevieve E; Hosking, Kelly; Banz, Kelly; Gargan, Catherine; Stewart, Geoff; Greenwood-Smith, Belinda; Ramsay, Penelope; Tate-Baker, Jaclyn; Connors, Christine; Binks, Paula; McKinnon, Melita; Manchikanti, Prashanti; Gurruwiwi, George Garambaka; Allard, Nicole; Qama, Ashleigh; Michaels, Jessica; Vintour-Cesar, Emily; Batey, Robert; Marshall, Catherine; Nihill, Peter; Fernandes, Tammy-Allyn; Fuller, Karen; Tong, Steven Y C; Boettiger, David; Cowie, Benjamin; Davis, Joshua S; Bukulatjpi, Sarah Mariyalawuy; Davies, Jane